The table below shows Twist Bioscience Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$47.63M
-$64.09M
-$142.47M
-$124.39M
-$112.24M
-$142.25M
Capital expenditure
$28.00M
$5.08M
$27.78M
$101.86M
$27.06M
$9.87M
Investing cash flow
-$24.76M
-$3.07M
$50.61M
-$232.93M
$156.16M
-$114.65M
Dividends paid
-
-
-
-
TWST operating cash flow (10-K history)
Twist Bioscience Corp reported operating cash flow of -$47.63M for fiscal year 2025. That is up 25.7% from -$64.09M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from -$51.30M (FY 2017) to -$47.63M. Figures come from the company's audited annual reports as filed with the SEC.
